FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anthony Cerami

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Ismayil Ahmet; Michael Brines; Anthony Cerami; Edward G Lakatta; Hyun-Jin Tae; Mark I Talan
Chronic administration of small nonerythropoietic Peptide sequence of erythropoietin effectively ameliorates the progression of postmyocardial infarction-dilated cardiomyopathy.
Stefan Bohr; Michael Brines; Anthony Cerami; Suraj J Patel; Keyue Shen; Antonia G Vitalo; Francois Berthiaume; Martin L Yarmush
Alternative erythropoietin-mediated signaling prevents secondary microvascular thrombosis and inflammation within cutaneous burns.
Michael Brines; Anthony Cerami
Erythropoietin and engineered innate repair activators.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anthony Cerami (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ismayil Ahmet; Michael Brines; Anthony Cerami; Edward G Lakatta; Hyun-Jin Tae; Mark I Talan
Chronic administration of small nonerythropoietic Peptide sequence of erythropoietin effectively ameliorates the progression of postmyocardial infarction-dilated cardiomyopathy.
The Journal of pharmacology and experimental therapeutics 2013;345(3):446-56.
2013: Stefan Bohr; Michael Brines; Anthony Cerami; Suraj J Patel; Keyue Shen; Antonia G Vitalo; Francois Berthiaume; Martin L Yarmush
Alternative erythropoietin-mediated signaling prevents secondary microvascular thrombosis and inflammation within cutaneous burns.
Proceedings of the National Academy of Sciences of the United States of America 2013;110(9):3513-8.
2013: Michael Brines; Anthony Cerami
Erythropoietin and engineered innate repair activators.
Methods in molecular biology (Clifton, N.J.) 2013;982():1-11.
2013: Jing Shi; Leendert A Trouw; Peter A van Veelen; Annemieke J Willemze; Anthony Cerami; Jan Wouter Drijfhout; Tom W J Huizinga; George M C Janssen; René E Toes
Recognition of citrullinated and carbamylated proteins by human antibodies: specificity, cross-reactivity and the 'AMC-Senshu' method.
Annals of the rheumatic diseases 2013;72(1):148-50.
2012: Anthony Cerami
TNF and EPO: major players in the innate immune response: their discovery.
Annals of the rheumatic diseases 2012;71 Suppl 2():i55-9.
2012: Lara Heij; Elske Hoitsma; Marieke Niesters; Maarten Swartjes; Oscar Vogels; Michael Brines; Anthony Cerami; Marjolein Drent; Ann Dunne; Jan C Grutters; Albert Dahan
Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, double-blind pilot study.
Molecular medicine (Cambridge, Mass.) 2012;18():1430-6.
2012: Nimesh S A Patel; Mara Rogazzo; Elizabeth G Wood; Muhammad M Yaqoob; Michael Brines; Anthony Cerami; Massimo Collino; Roberto Fantozzi; Florence L Johnson; Hannah L Kerr-Peterson; Christoph Thiemermann
Delayed administration of pyroglutamate helix B surface peptide (pHBSP), a novel nonerythropoietic analog of erythropoietin, attenuates acute kidney injury.
Molecular medicine (Cambridge, Mass.) 2012;18():719-27.
2012: Michael Brines; Anthony Cerami
The receptor that tames the innate immune response.
Molecular medicine (Cambridge, Mass.) 2012;18():486-96.
2011: Carmel M McVicar; Michael Brines; Anthony Cerami; Liza M Colhoun; Tom A Gardiner; Ross Hamilton; Alan W Stitt
Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy.
Diabetes 2011;60(11):2995-3005.
2011: Maarten Swartjes; Aurora Morariu; Marieke Niesters; Leon Aarts; Michael Brines; Anthony Cerami; Albert Dahan
ARA290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain: an experimental study in rats and β-common receptor knockout mice.
Anesthesiology 2011;115(5):1084-92.
2011: Jing Shi; Parawee Suwannalai; Rene E M Toes; Anthony Cerami; Tom W J Huizinga; George M C Janssen; Rachel Knevel; Nivine E W Levarht; Annette H M Van Der Helm-Van Mil; Michael P van der Linden; Peter A van Veelen; Leendert A Trouw
Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(42):17372-7.
2011: Nimesh S A Patel; Ws Fred Wong; Elisa Benetti; Michael Brines; Anthony Cerami; Massimo Collino; Roberto Fantozzi; Fera Y Goh; Amar Kapoor; Kiran K Nandra; Christoph Thiemermann
A nonerythropoietic peptide that mimics the 3D structure of erythropoietin reduces organ injury/dysfunction and inflammation in experimental hemorrhagic shock.
Molecular medicine (Cambridge, Mass.) 2011;17(9-10):883-92.
2011: Kamila Polgárová; Anthony Cerami; Petra Lüthje; Annelie Brauner
The erythropoietin analogue ARA290 modulates the innate immune response and reduces Escherichia coli invasion into urothelial cells.
FEMS immunology and medical microbiology 2011;62(2):190-6.
2011: Ismayil Ahmet; Hyun-Jin Tae; Magdalena Juhaszova; Daniel R Riordon; Kenneth R Boheler; STEVEN SOLLOTT; Michael Brines; Anthony Cerami; Edward G Lakatta; Mark I Talan
A small nonerythropoietic helix B surface peptide based upon erythropoietin structure is cardioprotective against ischemic myocardial damage.
Molecular medicine (Cambridge, Mass.) 2011;17(3-4):194-200.
2010: Kai Xu; Isaac George; Stefan Klotz; Ilan Hay; Steve Xydas; Geping Zhang; Anthony Cerami; Jie Wang
Erythropoietin derivate improves left ventricular systolic performance and attenuates left ventricular remodeling in rats with myocardial infarct-induced heart failure.
Journal of cardiovascular pharmacology 2010;56(5):506-12.
2010: Hiroto Ueba; Michael Brines; Michael Yamin; Tomio Umemoto; Junya Ako; Shin-ichi Momomura; Anthony Cerami; Masanobu Kawakami
Cardioprotection by a nonerythropoietic, tissue-protective peptide mimicking the 3D structure of erythropoietin.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(32):14357-62.
2009: Zübeyde Erbayraktar; Serhat Erbayraktar; Osman Yilmaz; Anthony Cerami; Thomas Coleman; Michael Brines
Nonerythropoietic tissue protective compounds are highly effective facilitators of wound healing.
Molecular medicine (Cambridge, Mass.) 2009;15(7-8):235-41.
2009: E Gunnarson; Yutong Song; Jacob M Kowalewski; hjalmar brismar; Michael Brines; Anthony Cerami; Ulf Andersson; Marina Zelenina; Anita Aperia
Erythropoietin modulation of astrocyte water permeability as a component of neuroprotection.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(5):1602-7.
2008: Michael Brines; Nimesh S A Patel; Pia Villa; Courtenay Brines; Tiziana Mennini; Massimiliano De Paola; Zubeyde Erbayraktar; Serhat Erbayraktar; Bruno Sepodes; Christoph Thiemermann; Pietro Ghezzi; Michael Yamin; Carla Hand; Qiao-Wen Xie; Thomas Coleman; Anthony Cerami
Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(31):10925-30.
2008: Era Taoufik; Edwige Petit; Didier Divoux; Vivian Tseveleki; Manuela Mengozzi; Michael Leslie Roberts; Samuel Valable; Pietro Ghezzi; John Quackenbush; Michael Brines; Anthony Cerami; Lesley Probert
TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(16):6185-90.
2007: Pia Villa; Johan van Beek; Anna Kirstine Larsen; Jens Gerwien; Søren Christensen; Anthony Cerami; Michael Brines; Marcel Leist; Pietro Ghezzi; Lars Torup
Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2007;27(3):552-63.
2006: Monica Fantacci; Paola Bianciardi; Anna Caretti; Thomas R Coleman; Anthony Cerami; Michael Brines; Michele Samaja
Carbamylated erythropoietin ameliorates the metabolic stress induced in vivo by severe chronic hypoxia.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(46):17531-6.
2006: Tiziana Mennini; Massimiliano De Paola; Paolo Bigini; Cristina Mastrotto; Elena Fumagalli; Sara Barbera; Manuela Mengozzi; Barbara Viviani; Emanuela Corsini; Marina Marinovich; Lars Torup; Johan van Beek; Marcel Leist; Michael Brines; Anthony Cerami; Pietro Ghezzi
Nonhematopoietic erythropoietin derivatives prevent motoneuron degeneration in vitro and in vivo.
Molecular medicine (Cambridge, Mass.) 2006;12(7-8):153-60.
2006: Michael Brines; Anthony Cerami
Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise.
Kidney international 2006;70(2):246-50.
2006: Roberto Bianchi; Michael Brines; Giuseppe Lauria; Costanza Savino; Alessandra Gilardini; Gabriella Nicolini; Virginia Rodriguez-Menendez; Norberto Oggioni; Annalisa Canta; Paola Penza; Raffaella Lombardi; Claudio Minoia; Anna Ronchi; Anthony Cerami; Pietro Ghezzi; Guido Cavaletti
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(8):2607-12.
2006: Thomas R Coleman; Christof Westenfelder; Florian Tögel; Ying Yang; Zhuma Hu; Leanne Swenson; Henri G D Leuvenink; Rutger J Ploeg; Livius V d'Uscio; Zvonimir S Katusic; Pietro Ghezzi; Adriana Zanetti; Kenneth Kaushansky; Norma E Fox; Anthony Cerami; Michael Brines
Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(15):5965-70.
2006: Serhat Erbayraktar; Nihal C de Lanerolle; Alain de Lotbinière; Jonathan Knisely; Zubeyde Erbayraktar; Osman Yilmaz; Anthony Cerami; Thomas R Coleman; Michael Brines
Carbamylated erythropoietin reduces radiosurgically-induced brain injury.
Molecular medicine (Cambridge, Mass.) 2006;12(4-6):74-80.
2006: Giovanni Grasso; Alessandra Sfacteria; Serhat Erbayraktar; Marcello Passalacqua; Francesco Meli; Necati Gokmen; Osman Yilmaz; Domenico La Torre; Michele Buemi; Domenico G Iacopino; Thomas Coleman; Anthony Cerami; Michael Brines; Francesco Tomasello
Amelioration of spinal cord compressive injury by pharmacological preconditioning with erythropoietin and a nonerythropoietic erythropoietin derivative.
Journal of neurosurgery. Spine 2006;4(4):310-8.
2006: Costanza Savino; Rosetta Pedotti; Fulvio Baggi; Federica Ubiali; Barbara Gallo; Sara Nava; Paolo Bigini; Sara Barbera; Elena Fumagalli; Tiziana Mennini; Annamaria Vezzani; Massimo Rizzi; Thomas Coleman; Anthony Cerami; Michael Brines; Pietro Ghezzi; Roberto Bianchi
Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis.
Journal of neuroimmunology 2006;172(1-2):27-37.
2005: Alfredo Gorio; Laura Madaschi; anna barbara di stefano; Stephana Carelli; Anna Maria Di Giulio; Silvia De Biasi; Thomas Coleman; Anthony Cerami; Michael Brines
Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(45):16379-84.
2005: Pietro Ghezzi; Anthony Cerami
Tumor necrosis factor as a pharmacological target.
Molecular biotechnology 2005;31(3):239-44.
2005: Michael Brines; Anthony Cerami
Emerging biological roles for erythropoietin in the nervous system.
Nature reviews. Neuroscience 2005;6(6):484-94.
2005: Fabio Fiordaliso; Stefano Chimenti; Lidia Staszewsky; Antonio Bai; Eleonora Carlo; Ivan Cuccovillo; Mirko Doni; Manuela Mengozzi; Rossella Tonelli; Pietro Ghezzi; Thomas Coleman; Michael Brines; Anthony Cerami; Roberto Latini
A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(6):2046-51.
2004: Michael Brines; Giovanni Grasso; Fabio Fiordaliso; Alessandra Sfacteria; Pietro Ghezzi; Maddalena Fratelli; Roberto Latini; Qiao-Wen Xie; John Smart; Chiao-Ju Su-Rick; Eileen Pobre; Deborah Diaz; Daniel Gomez; Carla Cerami Hand; Thomas Coleman; Anthony Cerami
Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(41):14907-12.
2004: Marcel Leist; Pietro Ghezzi; Giovanni Grasso; Roberto Bianchi; Pia Villa; Maddalena Fratelli; Costanza Savino; Marina Bianchi; Jacob Nielsen; Jens Gerwien; Pekka Kallunki; Anna Kirstine Larsen; Lone Helboe; Søren Christensen; Lars O Pedersen; Morten Nielsen; Lars Torup; Thomas Sager; Alessandra Sfacteria; Serhat Erbayraktar; Zubeyde Erbayraktar; Necati Gokmen; Osman Yilmaz; Carla Cerami Hand; Qiao-Wen Xie; Thomas Coleman; Anthony Cerami; Michael Brines
Derivatives of erythropoietin that are tissue protective but not erythropoietic.
Science (New York, N.Y.) 2004;305(5681):239-42.
2004: Robert N Butler; Huber R Warner; T Franklin Williams; Steven Austad; Jacob Brody ; Judith Campisi; Anthony Cerami; Gene Cohen; Vincent J Cristofalo; David Drachman; Caleb E Finch; Irwin Fridovich; Calvin B Harley; Richard J Havlik; George M Martin; Richard A Miller; S Jay Olshansky; Olivia M Pereira-Smith; James R Smith; Richard L Sprott; Michael D West; John R Wilmoth; Woodring E Wright
The aging factor in health and disease: the promise of basic research on aging.
Aging clinical and experimental research 2004;16(2):104-11; discussion 111-2.
2004: Giovanni Grasso; Alessandra Sfacteria; Anthony Cerami; Michael Brines
Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go?
The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry 2004;10(2):93-8.
2004: Roberto Bianchi; Belgin Buyukakilli; Michael Brines; Costanza Savino; Guido Cavaletti; Norberto Oggioni; Giuseppe Lauria; Monica Borgna; Raffaella Lombardi; Burak Cimen; Ulku Comelekoglu; Arzu Kanik; Cengiz Tataroglu; Anthony Cerami; Pietro Ghezzi
Erythropoietin both protects from and reverses experimental diabetic neuropathy.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(3):823-8.
2004: Pietro Ghezzi; Anthony Cerami
Tumor necrosis factor as a pharmacological target.
Methods in molecular medicine 2004;98():1-8.
2004: Tore Eid; Michael Brines; Anthony Cerami; Dennis D Spencer; Jung H Kim; Jeffrey S Schweitzer; Ole Petter Ottersen; Nihal C de Lanerolle
Increased expression of erythropoietin receptor on blood vessels in the human epileptogenic hippocampus with sclerosis.
Journal of neuropathology and experimental neurology 2004;63(1):73-83.
2004: Hannelore Ehrenreich; D Degner; J Meller; Michael Brines; M Béhé; Martin Hasselblatt; Helge Woldt; P Falkai; Friederike Knerlich; Sonja Jacob; Nicolas Von Ahsen; W Maier; W Brück; Eckart Rüther; Anthony Cerami; W Becker; Anna-Leena Sirén
Erythropoietin: a candidate compound for neuroprotection in schizophrenia.
Molecular psychiatry 2004;9(1):42-54.
2003: Pia Villa; Paolo Bigini; Tiziana Mennini; Davide Agnello; teresina laragione; Alfredo Cagnotto; Barbara Viviani; Marina Marinovich; Anthony Cerami; Thomas R Coleman; Michael Brines; Pietro Ghezzi
Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis.
The Journal of experimental medicine 2003;198(6):971-5.
2003: Serhat Erbayraktar; Giovanni Grasso; Alessandra Sfacteria; Qiao-Wen Xie; Thomas Coleman; Mads Kreilgaard; Lars Torup; Thomas Sager; Zubeyde Erbayraktar; Necati Gokmen; Osman Yilmaz; Pietro Ghezzi; Pia Villa; Maddalena Fratelli; Simona Casagrande; Marcel Leist; Lone Helboe; Jens Gerwein; Søren Christensen; Marie Geist; Lars Østergaard Pedersen; Carla Cerami Hand; Jean-Paul Wuerth; Anthony Cerami; Michael Brines
Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(11):6741-6.
2003: Laura Calvillo; Roberto Latini; Jan Kajstura; Annarosa Leri; Piero Anversa; Pietro Ghezzi; Monica Salio; Anthony Cerami; Michael Brines
Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(8):4802-6.
2002: Davide Agnello; Paolo Bigini; Pia Villa; Tiziana Mennini; Anthony Cerami; Michael Brines; Pietro Ghezzi
Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis.
Brain research 2002;952(1):128-34.
2002: Anna Junk; Antonios Mammis; Sean I Savitz; Manjeet Singh; Steven Roth; Samit Malhotra; Pearl S Rosenbaum; Anthony Cerami; Michael Brines; Daniel M Rosenbaum
Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(16):10659-64.
2002: Hannelore Ehrenreich; Martin Hasselblatt; Christoph Dembowski; Lukas Cepek; Piotr Lewczuk; Michael Stiefel; Hans-Heino Rustenbeck; Norbert Breiter; Sonja Jacob; Friederike Knerlich; Matthias Bohn; Wolfgang Poser; Eckart Rüther; Michael Kochen; Olaf Gefeller; Christoph Gleiter; Thomas C Wessel; Marc De Ryck; Loretta Itri; Hilmar Prange; Anthony Cerami; Michael Brines; Anna-Leena Sirén
Erythropoietin therapy for acute stroke is both safe and beneficial.
Molecular medicine (Cambridge, Mass.) 2002;8(8):495-505.
2002: Alfredo Gorio; Necati Gokmen; Serhat Erbayraktar; Osman Yilmaz; Laura Madaschi; Cinzia Cichetti; Anna Maria Di Giulio; Enver Vardar; Anthony Cerami; Michael Brines
Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(14):9450-5.
2002: Murat Celik; Necati Gökmen; Serhat Erbayraktar; Mustafa Akhisaroglu; Selman Konakc; Cagnur Ulukus; Sermin Genc; Kursad Genc; Emel Sagiroglu; Anthony Cerami; Michael Brines
Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(4):2258-63.
2002: Anthony Cerami; Michael Brines; Pietro Ghezzi; Carla Cerami Hand; Loretta M Itri
Neuroprotective properties of epoetin alfa.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17 Suppl 1():8-12.
2001: Anthony Cerami; Michael Brines; Pietro Ghezzi; Carla Cerami Hand
Effects of epoetin alfa on the central nervous system.
Seminars in oncology 2001;28(2 Suppl 8):66-70.
2001: Anna-Leena Sirén; Maddalena Fratelli; Michael Brines; Christoph G Goemans; Simona Casagrande; Piotr Lewczuk; S Keenan; C Gleiter; C Pasquali; A Capobianco; T Mennini; Rolf Heumann; Anthony Cerami; H Ehrenreich; Pietro Ghezzi
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(7):4044-9.
2001: Peter Vietas Vaitkevicius; M Lane; Harold A Spurgeon; Donald Ingram; George S Roth; J J Egan; S Vasan; DR Wagle; PC Ulrich; Michael Brines; J P Wuerth; Anthony Cerami; Edward G Lakatta
A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(3):1171-5.
2001: Anthony Cerami; PC Ulrich
Pharmaceutical intervention of advanced glycation endproducts.
Novartis Foundation symposium 2001;235():202-12; discussion 212-6, 217-20.
2001: PC Ulrich; Anthony Cerami
Protein glycation, diabetes, and aging.
Recent progress in hormone research 2001;56():1-21.
2000: Michael Brines; Pietro Ghezzi; S Keenan; Davide Agnello; Nihal C de Lanerolle; Carla Cerami Hand; L M Itri; Anthony Cerami
Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(19):10526-31.
2000: M Asif; J Egan; S Vasan; Garikiparthy N Jyothirmayi; Malthi Masurekar; S Lopez; C Williams; R L Torres; DR Wagle; PC Ulrich; Anthony Cerami; Michael Brines; Timothy J Regan
An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(6):2809-13.
1999: Yousef Al-Abed; T Mitsuhashi; H Li; J A Lawson; garret fitzgerald; HW Founds; T Donnelly; Anthony Cerami; PC Ulrich; Richard Bucala
Inhibition of advanced glycation endproduct formation by acetaldehyde: role in the cardioprotective effect of ethanol.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(5):2385-90.
1999: JA Martiney; A S Ferrer; Anthony Cerami; S Dzekunov; Paul D Roepe
Chloroquine uptake, altered partitioning and the basis of drug resistance: evidence for chloride-dependent ionic regulation.
Novartis Foundation symposium 1999;226():265-77; discussion 277-80.
1998: Barbara Sherry; M Espinoza; K R Manogue; Anthony Cerami
Induction of the chemokine beta peptides, MIP-1 alpha and MIP-1 beta, by lipopolysaccharide is differentially regulated by immunomodulatory cytokines gamma-IFN, IL-10, IL-4, and TGF-beta.
Molecular medicine (Cambridge, Mass.) 1998;4(10):648-57.
1998: JA Martiney; AJ Rajan; Peter Charles; Anthony Cerami; PC Ulrich; S Macphail; Kevin Tracey; Celia F Brosnan
Prevention and treatment of experimental autoimmune encephalomyelitis by CNI-1493, a macrophage-deactivating agent.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(11):5588-95.
1998: Omar Haffar; M D Smithgall; Serguei Popov; P Ulrich; A G Bruce; Steven G Nadler; Anthony Cerami; Michael Bukrinsky
CNI-H0294, a nuclear importation inhibitor of the human immunodeficiency virus type 1 genome, abrogates virus replication in infected activated peripheral blood mononuclear cells.
Antimicrobial agents and chemotherapy 1998;42(5):1133-8.
1998: Bruce Wolffenbuttel; Chantal M Boulanger; FR Crijns; Maya S P Huijberts; P Poitevin; G N Swennen; S Vasan; J J Egan; PC Ulrich; Anthony Cerami; Bernard I Lévy
Breakers of advanced glycation end products restore large artery properties in experimental diabetes.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(8):4630-4.
1998: Barbara Sherry; Gabriele Zybarth; Massimo Alfano; Larisa Dubrovsky; R Mitchell; D Rich; PC Ulrich; Richard Bucala; Anthony Cerami; Michael Bukrinsky
Role of cyclophilin A in the uptake of HIV-1 by macrophages and T lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(4):1758-63.
1997: Carla Cerami Hand; HW Founds; Iain Nicholl; T Mitsuhashi; D Giordano; S Vanpatten; A Lee; Yousef Al-Abed; H Vlassara; Richard Bucala; Anthony Cerami
Tobacco smoke is a source of toxic reactive glycation products.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(25):13915-20.
1997: A Paciorkowski; Wei Wei Dai; Anthony Cerami; BJ Berger
Synergism of cimetidine with anti-malarial agents.
The Journal of parasitology 1997;83(5):960-3.
1997: BJ Berger; Wei Wei Dai; Anthony Cerami; PC Ulrich
Studies on the mechanism of antimalarial action of a novel arylene bis(methylketone).
Biochemical pharmacology 1997;54(6):739-42.
1997: M Zhang; T Caragine; Hong Wang; PS Cohen; GI Botchkina; K Soda; M Bianchi; PC Ulrich; Anthony Cerami; Barbara Sherry; Kevin Tracey
Spermine inhibits proinflammatory cytokine synthesis in human mononuclear cells: a counterregulatory mechanism that restrains the immune response.
The Journal of experimental medicine 1997;185(10):1759-68.
1997: BJ Berger; M Suskin; Wei Wei Dai; Anthony Cerami; PC Ulrich
Studies on the pharmacological properties of novel arylene bis(methylketone) compounds using solid-phase extraction and high-performance liquid chromatography.
Journal of chromatography. B, Biomedical sciences and applications 1997;691(2):433-40.
1996: Serguei Popov; Larisa Dubrovsky; M A Lee; Sridhar Pennathur; Omar Haffar; Y aL-Abed; P Tonge; PC Ulrich; M Rexach; Günter Blobel; Anthony Cerami; Michael Bukrinsky
Critical role of reverse transcriptase in the inhibitory mechanism of CNI-H0294 on HIV-1 nuclear translocation.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(21):11859-64.
1996: BJ Berger; A Paciorkowski; M Suskin; Wei Wei Dai; Anthony Cerami; P Ulrich
Antimalarial activity of novel arylene bis(methylketone) compounds.
The Journal of infectious diseases 1996;174(3):659-62.
1996: S Vasan; X Zhang; X Zhang; Aphrodite Kapurniotu; Jürgen Bernhagen; S Teichberg; J Basgen; D Wagle; D Shih; I Terlecky; Richard Bucala; Anthony Cerami; J Egan; PC Ulrich
An agent cleaving glucose-derived protein crosslinks in vitro and in vivo.
Nature 1996;382(6588):275-8.
1996: BJ Berger; Wei Wei Dai; Hong Wang; R E Stark; Anthony Cerami
Aromatic amino acid transamination and methionine recycling in trypanosomatids.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(9):4126-30.
1996: P S Cohen; Harikrishna Nakshatri; J Dennis; T Caragine; M Bianchi; Anthony Cerami; Kevin Tracey
CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(9):3967-71.
1996: J A Martiney; Anthony Cerami; A F Slater
Inhibition of hemozoin formation in Plasmodium falciparum trophozoite extracts by heme analogs: possible implication in the resistance to malaria conferred by the beta-thalassemia trait.
Molecular medicine (Cambridge, Mass.) 1996;2(2):236-46.
1996: M Bianchi; O Bloom; T Raabe; P S Cohen; Jason Chesney; Barbara Sherry; Helena Schmidtmayerova; T Calandra; X Zhang; Michael Bukrinsky; PC Ulrich; Anthony Cerami; Kevin Tracey
Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone.
The Journal of experimental medicine 1996;183(3):927-36.
1996: Helena Schmidtmayerova; H S Nottet; G Nuovo; T Raabe; C R Flanagan; Larisa Dubrovsky; Howard E Gendelman; Anthony Cerami; Michael Bukrinsky; Barbara Sherry
Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(2):700-4.
1995: BJ Berger; J Martiney; A F Slater; Alan H Fairlamb; Anthony Cerami
Chloroquine resistance is not associated with drug metabolism in Plasmodium falciparum.
The Journal of parasitology 1995;81(6):1004-8.
1995: K Bendrat; BJ Berger; Anthony Cerami
Haem polymerization in malaria.
Nature 1995;378(6553):138-9.
1995: BJ Berger; K Bendrat; Anthony Cerami
High-performance liquid chromatographic analysis of biological and chemical heme polymerization.
Analytical biochemistry 1995;231(1):151-6.
1995: J A Martiney; Anthony Cerami; A F Slater
Verapamil reversal of chloroquine resistance in the malaria parasite Plasmodium falciparum is specific for resistant parasites and independent of the weak base effect.
The Journal of biological chemistry 1995;270(38):22393-8.
1995: T Calandra; Jürgen Bernhagen; Christine N Metz; L A Spiegel; Michael Bacher; T Donnelly; Anthony Cerami; Richard Bucala
MIF as a glucocorticoid-induced modulator of cytokine production.
Nature 1995;377(6544):68-71.
1995: H Vlassara; YM Li; F Imani; D Wojciechowicz; Z Yang; Fu-Tong Liu; Anthony Cerami
Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex.
Molecular medicine (Cambridge, Mass.) 1995;1(6):634-46.
1995: M Bukrinsky; K Manogue; Anthony Cerami
HIV results in the frame. Other approaches.
Nature 1995;375(6528):195-6; author reply 198.
1995: Richard Bucala; R Mitchell; K Arnold; T Innerarity; H Vlassara; Anthony Cerami
Identification of the major site of apolipoprotein B modification by advanced glycosylation end products blocking uptake by the low density lipoprotein receptor.
The Journal of biological chemistry 1995;270(18):10828-32.
1995: G A Zimmerman; M Meistrell; O Bloom; K M Cockroft; M Bianchi; D Risucci; J Broome; P Farmer; Anthony Cerami; H Vlassara
Neurotoxicity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidine.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(9):3744-8.
1995: Larisa Dubrovsky; PC Ulrich; G J Nuovo; K R Manogue; Anthony Cerami; Michael Bukrinsky
Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.
Molecular medicine (Cambridge, Mass.) 1995;1(2):217-30.
1995: A T Lee; A Plump; C DeSimone; Anthony Cerami; Richard Bucala
A role for DNA mutations in diabetes-associated teratogenesis in transgenic embryos.
Diabetes 1995;44(1):20-4.
1995: B A Sherry; G Alava; Kevin Tracey; J Martiney; Anthony Cerami; A F Slater
Malaria-specific metabolite hemozoin mediates the release of several potent endogenous pyrogens (TNF, MIP-1 alpha, and MIP-1 beta) in vitro, and altered thermoregulation in vivo.
Journal of inflammation 1995;45(2):85-96.
1994: Jürgen Bernhagen; R A Mitchell; T Calandra; Wolfgang Voelter; Anthony Cerami; Richard Bucala
Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF).
Biochemistry 1994;33(47):14144-55.
1994: Richard Bucala; L A Spiegel; Jason Chesney; M Hogan; Anthony Cerami
Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair.
Molecular medicine (Cambridge, Mass.) 1994;1(1):71-81.
1994: Richard Bucala; Z Makita; G Vega; S Grundy; T Koschinsky; Anthony Cerami; H Vlassara
Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(20):9441-5.
1994: Jürgen Bernhagen; T Calandra; Anthony Cerami; Richard Bucala
Macrophage migration inhibitory factor is a neuroendocrine mediator of endotoxaemia.
Trends in microbiology 1994;2(6):198-201.
1994: Michael P. Vitek; K Bhattacharya; J M Glendening; Edward G Stopa; H Vlassara; Richard Bucala; K Manogue; Anthony Cerami
Advanced glycation end products contribute to amyloidosis in Alzheimer disease.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(11):4766-70.
1994: A T Lee; C DeSimone; Anthony Cerami; Richard Bucala
Comparative analysis of DNA mutations in lacI transgenic mice with age.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1994;8(8):545-50.
1994: Kevin Tracey; Anthony Cerami
Tumor necrosis factor: a pleiotropic cytokine and therapeutic target.
Annual review of medicine 1994;45():491-503.
1994: M Hogan; Barbara Sherry; C Ritchlin; M Fabre; R Winchester; Anthony Cerami; Richard Bucala
Differential expression of the small inducible cytokines GRO alpha and GRO beta by synovial fibroblasts in chronic arthritis: possible role in growth regulation.
Cytokine 1994;6(1):61-9.
1993: Jürgen Bernhagen; T Calandra; R A Mitchell; S B Martin; Kevin Tracey; Wolfgang Voelter; K R Manogue; Anthony Cerami; Richard Bucala
MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia.
Nature 1993;365(6448):756-9.
1993: Richard Bucala; Z Makita; T Koschinsky; Anthony Cerami; H Vlassara
Lipid advanced glycosylation: pathway for lipid oxidation in vivo.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(14):6434-8.
1993: RD Myers; X Paez; A K Roscoe; Barbara Sherry; Anthony Cerami
Fever and feeding: differential actions of macrophage inflammatory protein-1 (MIP-1), MIP-1 alpha and MIP-1 beta on rat hypothalamus.
Neurochemical research 1993;18(6):667-73.
1993: U Widmer; K R Manogue; Anthony Cerami; Barbara Sherry
Genomic cloning and promoter analysis of macrophage inflammatory protein (MIP)-2, MIP-1 alpha, and MIP-1 beta, members of the chemokine superfamily of proinflammatory cytokines.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(11):4996-5012.
1993: Hal E Broxmeyer; Barbara Sherry; Scott Cooper; L Lu; R Maze; M P Beckmann; Anthony Cerami; P Ralph
Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(8 Pt 1):3448-58.
1993: Richard Bucala; A T Lee; L Rourke; Anthony Cerami
Transposition of an Alu-containing element induced by DNA-advanced glycosylation endproducts.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(7):2666-70.
1993: Kevin Tracey; Anthony Cerami
Tumor necrosis factor, other cytokines and disease.
Annual review of cell biology 1993;9():317-43.
1993: Anthony Cerami
Tumor necrosis factor as a mediator of shock, cachexia and inflammation.
Blood purification 1993;11(2):108-17.
1992: H Vlassara; H Fuh; Z Makita; S Krungkrai; Anthony Cerami; Richard Bucala
Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(24):12043-7.
1992: A T Lee; Anthony Cerami
Role of glycation in aging.
Annals of the New York Academy of Sciences 1992;663():63-70.
1992: Z Makita; H Vlassara; E Rayfield; K Cartwright; E Friedman; R Rodby; Anthony Cerami; Richard Bucala
Hemoglobin-AGE: a circulating marker of advanced glycosylation.
Science (New York, N.Y.) 1992;258(5082):651-3.
1992: M Hogan; Anthony Cerami; R Bucala
Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus.
The Journal of clinical investigation 1992;90(3):1110-5.
1992: R Maze; Barbara Sherry; Byoung S Kwon; Anthony Cerami; Hal E Broxmeyer
Myelosuppressive effects in vivo of purified recombinant murine macrophage inflammatory protein-1 alpha.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(3):1004-9.
1992: E Lolis; R M Sweet; L S Cousens; P Tekamp-Olson; Barbara Sherry; Anthony Cerami
Preliminary crystallographic analysis of murine macrophage inflammatory protein 2.
Journal of molecular biology 1992;225(3):913-5.
1992: T J Fahey; Kevin Tracey; P Tekamp-Olson; L S Cousens; W G Jones; G T Shires; Anthony Cerami; Barbara Sherry
Macrophage inflammatory protein 1 modulates macrophage function.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(9):2764-9.
1992: Barbara Sherry; N Yarlett; A Strupp; Anthony Cerami
Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(8):3511-5.
1992: Z Makita; H Vlassara; Anthony Cerami; Richard Bucala
Immunochemical detection of advanced glycosylation end products in vivo.
The Journal of biological chemistry 1992;267(8):5133-8.
1992: A F Slater; Anthony Cerami
Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites.
Nature 1992;355(6356):167-9.
1992: Anthony Cerami
Inflammatory cytokines.
Clinical immunology and immunopathology 1992;62(1 Pt 2):S3-10.
1992: H Field; Anthony Cerami; G B Henderson
Cloning, sequencing, and demonstration of polymorphism in trypanothione reductase from Crithidia fasciculata.
Molecular and biochemical parasitology 1992;50(1):47-56.
1992: Barbara Sherry; Y Horii; K R Manogue; U Widmer; Anthony Cerami
Macrophage inflammatory proteins 1 and 2: an overview.
Cytokines 1992;4():117-30.
1991: Hal E Broxmeyer; Barbara Sherry; Scott Cooper; F W Ruscetti; D E Williams; paolo arosio; Byoung S Kwon; Anthony Cerami
Macrophage inflammatory protein (MIP)-1 beta abrogates the capacity of MIP-1 alpha to suppress myeloid progenitor cell growth.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(8):2586-94.
1991: G B Henderson; N J Murgolo; John Kuriyan; K Osapay; D Kominos; A Berry; Nigel Scrutton; N W Hinchliffe; R N Perham; Anthony Cerami
Engineering the substrate specificity of glutathione reductase toward that of trypanothione reduction.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(19):8769-73.
1991: John Kuriyan; X P Kong; T S Krishna; R M Sweet; N J Murgolo; H Field; Anthony Cerami; G B Henderson
X-ray structure of trypanothione reductase from Crithidia fasciculata at 2.4-A resolution.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(19):8764-8.
1991: Z Makita; S Radoff; E J Rayfield; Z Yang; E Skolnik; V Delaney; Eli A Friedman; Anthony Cerami; H Vlassara
Advanced glycosylation end products in patients with diabetic nephropathy.
The New England journal of medicine 1991;325(12):836-42.
1991: Z Yang; Z Makita; Y Horii; S Brunelle; Anthony Cerami; Prabodh K Sehajpal; Manikkam Suthanthiran; H Vlassara
Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins.
The Journal of experimental medicine 1991;174(3):515-24.
1991: A T Lee; Anthony Cerami
Induction of gamma delta transposition in response to elevated glucose-6-phosphate levels.
Mutation research 1991;249(1):125-33.
1991: U Widmer; Z Yang; S van Deventer; K R Manogue; Barbara Sherry; Anthony Cerami
Genomic structure of murine macrophage inflammatory protein-1 alpha and conservation of potential regulatory sequences with a human homolog, LD78.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(11):4031-40.
1991: D E Goldberg; A F Slater; Ronald C Beavis; Brian T Chait; Anthony Cerami; G B Henderson
Hemoglobin degradation in the human malaria pathogen Plasmodium falciparum: a catabolic pathway initiated by a specific aspartic protease.
The Journal of experimental medicine 1991;173(4):961-9.
1991: Richard Bucala; C Ritchlin; Robert Winchester; Anthony Cerami
Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts.
The Journal of experimental medicine 1991;173(3):569-74.
1991: J Krungkrai; Anthony Cerami; G B Henderson
Purification and characterization of dihydroorotate dehydrogenase from the rodent malaria parasite Plasmodium berghei.
Biochemistry 1991;30(7):1934-9.
1991: Barbara Sherry; Anthony Cerami
Small cytokine superfamily.
Current opinion in immunology 1991;3(1):56-60.
1991: R Bucala; Kevin Tracey; Anthony Cerami
Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.
The Journal of clinical investigation 1991;87(2):432-8.
1991: A F Slater; W J Swiggard; B R Orton; W D Flitter; D E Goldberg; Anthony Cerami; G B Henderson
An iron-carboxylate bond links the heme units of malaria pigment.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(2):325-9.
1990: Kevin Tracey; S Morgello; B Koplin; T J Fahey; J Fox; A Aledo; K R Manogue; Anthony Cerami
Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia.
The Journal of clinical investigation 1990;86(6):2014-24.
1990: S Radoff; Anthony Cerami; H Vlassara
Isolation of surface binding protein specific for advanced glycosylation end products from mouse macrophage-derived cell line RAW 264.7.
Diabetes 1990;39(12):1510-8.
1990: John Kuriyan; L Wong; B D Guenther; N J Murgolo; Anthony Cerami; G B Henderson
Preliminary crystallographic analysis of trypanothione reductase from Crithidia fasciculata.
Journal of molecular biology 1990;215(3):335-7.
1990: C E Luedke; Anthony Cerami
Interferon-gamma overcomes glucocorticoid suppression of cachectin/tumor necrosis factor biosynthesis by murine macrophages.
The Journal of clinical investigation 1990;86(4):1234-40.
1990: Hal E Broxmeyer; Barbara Sherry; L Lu; Scott Cooper; K O Oh; P Tekamp-Olson; Byoung S Kwon; Anthony Cerami
Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells.
Blood 1990;76(6):1110-6.
1990: D M Jue; Barbara Sherry; C Luedke; K R Manogue; Anthony Cerami
Processing of newly synthesized cachectin/tumor necrosis factor in endotoxin-stimulated macrophages.
Biochemistry 1990;29(36):8371-7.
1990: P Tekamp-Olson; C Gallegos; D Bauer; J McClain; Barbara Sherry; M Fabre; S van Deventer; Anthony Cerami
Cloning and characterization of cDNAs for murine macrophage inflammatory protein 2 and its human homologues.
The Journal of experimental medicine 1990;172(3):911-9.
1990: J Krungkrai; Anthony Cerami; G B Henderson
Pyrimidine biosynthesis in parasitic protozoa: purification of a monofunctional dihydroorotase from Plasmodium berghei and Crithidia fasciculata.
Biochemistry 1990;29(26):6270-5.
1990: Francisco J Miñano; M Sancibrian; M Vizcaino; X Paez; G Davatelis; T Fahey; Barbara Sherry; Anthony Cerami; RD Myers
Macrophage inflammatory protein-1: unique action on the hypothalamus to evoke fever.
Brain research bulletin 1990;24(6):849-52.
1990: A T Lee; Anthony Cerami
In vitro and in vivo reactions of nucleic acids with reducing sugars.
Mutation research 1990;238(3):185-91.
1990: G B Henderson; M Yamaguchi; L Novoa; Alan H Fairlamb; Anthony Cerami
Biosynthesis of the trypanosomatid metabolite trypanothione: purification and characterization of trypanothione synthetase from Crithidia fasciculata.
Biochemistry 1990;29(16):3924-9.
1990: D E Goldberg; A F Slater; Anthony Cerami; G B Henderson
Hemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelle.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(8):2931-5.
1990: M Kinkhabwala; Prabodh K Sehajpal; E Skolnik; D Smith; V K Sharma; H Vlassara; Anthony Cerami; Manikkam Suthanthiran
A novel addition to the T cell repertory. Cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells.
The Journal of experimental medicine 1990;171(3):941-6.
1990: K Saukkonen; S Sande; C Cioffe; S Wolpe; Barbara Sherry; Anthony Cerami; Elaine I Tuomanen
The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis.
The Journal of experimental medicine 1990;171(2):439-48.
1989: S D Wolpe; Anthony Cerami
Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1989;3(14):2565-73.
1989: Hal E Broxmeyer; Barbara Sherry; L Lu; Scott Cooper; C Carow; S D Wolpe; Anthony Cerami
Myelopoietic enhancing effects of murine macrophage inflammatory proteins 1 and 2 on colony formation in vitro by murine and human bone marrow granulocyte/macrophage progenitor cells.
The Journal of experimental medicine 1989;170(5):1583-94.
1989: Kevin Tracey; Anthony Cerami
The role of cachectin/tumor necrosis factor in AIDS.
Cancer cells (Cold Spring Harbor, N.Y. : 1989) 1989;1(2):62-3.
1989: Barbara Sherry; J Gelin; Yuman Fong; M Marano; H Wei; Anthony Cerami; Stephen F Lowry; Kent Lundholm; L L Moldawer
Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1989;3(8):1956-62.
1989: Alan H Fairlamb; G B Henderson; Anthony Cerami
Trypanothione is the primary target for arsenical drugs against African trypanosomes.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(8):2607-11.
1989: G Davatelis; S D Wolpe; Barbara Sherry; J M Dayer; R Chicheportiche; Anthony Cerami
Macrophage inflammatory protein-1: a prostaglandin-independent endogenous pyrogen.
Science (New York, N.Y.) 1989;243(4894 Pt 1):1066-8.
1989: A T Lee; Anthony Cerami
Nonenzymatic glycosylation of DNA by reducing sugars.
Progress in clinical and biological research 1989;304():291-9.
1989: N J Murgolo; Anthony Cerami; G B Henderson
Biomedical science and the third world. Under the volcano. Trypanothione reductase.
Annals of the New York Academy of Sciences 1989;569():193-200.
1989: S D Wolpe; Barbara Sherry; D Juers; G Davatelis; R W Yurt; Anthony Cerami
Identification and characterization of macrophage inflammatory protein 2.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(2):612-6.
1989: H Vlassara; Michael Brownlee; Anthony Cerami
Macrophage receptor-mediated processing and regulation of advanced glycosylation endproduct (AGE)-modified proteins: role in diabetes and aging.
Progress in clinical and biological research 1989;304():205-18.
1988: Barbara Sherry; P Tekamp-Olson; C Gallegos; D Bauer; G Davatelis; S D Wolpe; F Masiarz; D Coit; Anthony Cerami
Resolution of the two components of macrophage inflammatory protein 1, and cloning and characterization of one of those components, macrophage inflammatory protein 1 beta.
The Journal of experimental medicine 1988;168(6):2251-9.
1988: G B Henderson; P Ulrich; Alan H Fairlamb; I Rosenberg; M Pereira; M Sela; Anthony Cerami
"Subversive" substrates for the enzyme trypanothione disulfide reductase: alternative approach to chemotherapy of Chagas disease.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(15):5374-8.
1988: S Radoff; H Vlassara; Anthony Cerami
Characterization of a solubilized cell surface binding protein on macrophages specific for proteins modified nonenzymatically by advanced glycosylated end products.
Archives of biochemistry and biophysics 1988;263(2):418-23.
1988: G Davatelis; P Tekamp-Olson; S D Wolpe; K Hermsen; C Luedke; C Gallegos; D Coit; J Merryweather; Anthony Cerami
Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokinetic properties.
The Journal of experimental medicine 1988;167(6):1939-44.
1988: H Vlassara; Michael Brownlee; Anthony Cerami
Specific macrophage receptor activity for advanced glycosylation end products inversely correlates with insulin levels in vivo.
Diabetes 1988;37(4):456-61.
1988: S D Wolpe; G Davatelis; Barbara Sherry; Bruce Beutler; D G Hesse; H T Nguyen; L L Moldawer; C F Nathan; Stephen F Lowry; Anthony Cerami
Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties.
The Journal of experimental medicine 1988;167(2):570-81.
1987: A T Lee; Anthony Cerami
Elevated glucose 6-phosphate levels are associated with plasmid mutations in vivo.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(23):8311-4.
1987: Shigeru Sassa; S Wolpe; Anthony Cerami
Inhibition of erythroid differentiation of mouse erythroleukemia cells by a macrophage product(s).
Blood cells 1987;13(1-2):161-9.
1987: Kevin Tracey; Stephen F Lowry; Anthony Cerami
Physiological responses to cachectin.
Ciba Foundation symposium 1987;131():88-108.